francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

239
Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004;
117:239-51.
Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. Molecular genetic
evidence of the occurrence of breast cancer as an integral tumor in patients
with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer
1996; 77:1836-43.
Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in
young women. J Clin Oncol 1998; 16:1642-9.
Rush LJ, Raval A, Funchain P, et al. Epigenetic profiling in chronic
lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004;
64:2424-33.
Sawasaki T, Shigemasa K, Gu L, Beard JB, O'Brien TJ. The transmembrane
protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for
diagnosis and therapeutic intervention in ovarian cancer. Tumour Biol 2004;
25:141-8.
Schang LM, Bantly A, Schaffer PA. Explant-induced reactivation of herpes
simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J Virol
2002; 76:7724-35.
Schutte M, Seal S, Barfoot R, et al. Variants in CHEK2 other than 1100delC
do not make a major contribution to breast cancer susceptibility. Am J Hum
Genet 2003; 72:1023-8.
Scott KL, Plon SE. CHES1/FOXN3 interacts with Ski-interacting protein and
acts as a transcriptional repressor. Gene 2005; 359:119-26.